Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion

Pathological sodium-water retention or edema/congestion is a primary cause of heart failure (HF) decompensation, clinical symptoms, hospitalization, reduced quality of life, and premature mortality. Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) based therapies reduce hospitalization due to HF,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Michelle, Sullivan, Ryan D., McCune, Mariana E., Reed, Guy L., Gladysheva, Inna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024630/
https://www.ncbi.nlm.nih.gov/pubmed/35454037
http://dx.doi.org/10.3390/diagnostics12040989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024630/
https://www.ncbi.nlm.nih.gov/pubmed/35454037
http://dx.doi.org/10.3390/diagnostics12040989

Ejemplares similares